Hepatitis b Trials in Brussels, Belgium
Conditions / Hepatitis b / Brussels, Belgium
Hepatitis b has been the subject of sustained clinical investigation across multiple research sites.
19 total trials for this combination
Showing top 10 of 19 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02479880 | Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection | TERMINATED | PHASE4 |
| NCT00291980 | A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody. | COMPLETED | PHASE3 |
| NCT00291954 | Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination | COMPLETED | PHASE3 |
| NCT00805389 | Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine | COMPLETED | PHASE2 |
| NCT00197184 | Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared | COMPLETED | PHASE3 |
| NCT00645294 | Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV | COMPLETED | PHASE1/PHASE2 |
| NCT00291941 | A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B. | COMPLETED | PHASE3 |
| NCT06537414 | A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT03361956 | An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection | COMPLETED | PHASE2 |
| NCT02699736 | EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV | ENROLLING_BY_INVITATION | — |